Unlock instant, AI-driven research and patent intelligence for your innovation.

Method of countering respiratory depression via activation of neuronal heteromeric nicotinic acetylcholine receptors

A technology of acetylcholine receptors and respiratory depression, applied in the fields of respiratory diseases, nervous system diseases, anti-inflammatory agents, etc.

Inactive Publication Date: 2020-09-04
THE GOVERNORS OF THE UNIV OF ALBERTA
View PDF8 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Solubility limitations of amparkine mean that only oral formulations are currently available in clinical trials, and they are associated with a delay in reaching therapeutic plasma levels (>1 hour) of amparkine
Therefore, drug treatments that rapidly reduce OIRD without interfering with the desired analgesic effect and without inducing significant side effects remain an unmet clinical need

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method of countering respiratory depression via activation of neuronal heteromeric nicotinic acetylcholine receptors
  • Method of countering respiratory depression via activation of neuronal heteromeric nicotinic acetylcholine receptors
  • Method of countering respiratory depression via activation of neuronal heteromeric nicotinic acetylcholine receptors

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0097] Example 1 -Effects of co-administration of fentanyl and drugs targeting α4β2 nAChR in vivo using adult rats

[0098] Plethysmographic recordings from adult rats were used to examine coadministration of drugs targeting α4β2 nAChRs (A85380, rivancillin, NS9283) with fentanyl to determine whether it could significantly reduce OIRD levels and reduce fatal overdose. Simultaneously monitor the level of analgesia to assess whether there is an additive effect of nAChR-targeting drugs and fentanyl.

[0099] figure 1 is a schematic diagram of the experimental protocol (Ren (Ren) et al., 2015). Briefly, three nociceptive testing methods and sedation were performed in addition to the measurement of respiratory parameters. Righting reflex testing was initiated 6-10 min after opioid administration and continued until the animal awoke from fentanyl-induced sedation. Tail clamping began 12 minutes after the opioid infusion and was repeated every 4 minutes. When the animal regain...

Embodiment 2

[0112] Example 2 - First-aid efficacy of α4β2 nAChR-targeted drugs (A85380, rivancillin, or NS9283) for fentanyl-induced respiratory depression

[0113] In vivo experiments were performed to determine whether an α4β2 nAChR-targeted drug could be used as a first-aid intervention against severe fentanyl-induced respiratory depression and lethality. The data showed that all three drugs had some positive effects, with the full agonist A85380 showing the strongest effect.

[0114] The advantage over naloxone is the maintenance of analgesic effect. This regimen achieves significant respiratory depression following a 6-minute continuous infusion of fentanyl (60 μg / kg for 20 minutes) in one tail vein or lethal following a 1-minute bolus infusion (80 μg / kg for 1 minute) Sexual apnea. A bolus of α4β2-targeted drug or vehicle was then administered into another tail vein injection to assess the efficacy of rescue from respiratory depression.

[0115] It was determined whether intramu...

Embodiment 3

[0119] Example 3 -μ-opioids and Mechanistic investigation of the interplay of α4β2 nACh receptor activation in inspiratory neurons and XII motor neurons

[0120] Detection of Opioid Agents and α4β2 nAChR Targeting Drug Pairs Using Recordings of Neural Activity from In Vitro Agents and Whole-Cell Patch Recordings Mechanism of action of neurons and XII motor neurons. use for and XII motor neuron populations in medullary slice preparations that generate robust, rhythmic inspiratory activity (Funk, 2013). Sections of the medulla were cut at specific craniocaudal levels to expose and XII motor neuron populations (Ruangkittisakul et al., 2006). The use of infrared differential interference contrast microscopy provides clear visualization of neurons for the targeting of whole-cell patch electrodes.

[0121] Brainstem-spinal cord and medullary slice preparations were obtained from neonatal Sprague-Durer rats. Rats were anesthetized with methoxyflurane, brains were excised,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Compounds capable of activating a neuronal heteromeric nicotinic acetylcholine receptor are provided and can be administered in the form of pharmaceutical compositions of the like. Methods for using the compounds for treating, preventing, or ameliorating respiratory depression and overdose induced by an opioid, or other cause of respiratory depression are also provided. Methods of inducing analgesia, anesthesia, or sedation in a subject, while simultaneously treating, preventing, or ameliorating respiratory depression and overdose induced by an opioid, or other cause of respiratory depressionare also provided.

Description

[0001] inventor: Jun Ren; John Greer [0002] Assignee: University Council of Alberta technical field [0003] The present invention relates to the use of compounds targeting neuronal heteromericnicotinic acetylcholine receptors to treat, prevent or ameliorate respiratory depression and overdose in subjects caused by opioids or other causes of respiratory depression method, said other causes include non-opioid, obstructive sleep apnea, central sleep apnea, apnea of ​​prematurity, hypoxia, Prader-Willi Syndrome, Rett syndrome , Pompe disease, Cheyne-Stokes breathing, neuronal degeneration, stroke, heart failure, traumatic brain injury, Parkinson's disease, or spinal cord injury. Background technique [0004] Opioid analgesics are the most widely used effective drugs for the treatment of acute, postoperative and chronic pain (Swarm et al., 2001). However, activation of opiate receptors leads to inhibition of respiratory drive (Shook et al., 1990; Greer et al., 1995; Gray ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/4427A61K31/4406A61K31/4439A61K31/445A61K38/14A61P11/00A61P23/00A61P25/20A61P25/36A61P29/00C07D211/32C07D213/38C07D401/12C07D413/04
CPCA61K31/4406A61K31/4427A61K31/4439A61K31/445A61P11/00A61P25/20A61P25/36A61P29/00A61P23/00A61P11/16A61K31/40A61K31/422A61K31/55
Inventor 任军约翰·J·格里尔
Owner THE GOVERNORS OF THE UNIV OF ALBERTA